Transition from paediatric to adult endocrinology: Hypopituitarism

Growth Hormone and IGF Research

Volumn 14, Issue SUPPL. A, 2004, Pages

  Stanhope, Richard ^a,b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Adult; Optimisation of replacement therapy; Paediatric; Transition

Indexed keywords

GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; HYPOPHYSIS HORMONE; LIPID; SEX HORMONE; THYROID HORMONE; THYROXINE;

ADOLESCENT; ADULTHOOD; ARTICLE; CHILD CARE; CHILDHOOD; DIET RESTRICTION; DRUG BLOOD LEVEL; DRUG INHIBITION; ENDOCRINOLOGY; FAMILY; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HEALTH CARE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOPITUITARISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LIPID BLOOD LEVEL; MEDICAL SPECIALIST; MUSCLE WEAKNESS; OBESITY; ONSET AGE; OSTEOPENIA; OUTPATIENT DEPARTMENT; PATIENT ATTITUDE; PRIORITY JOURNAL; SKELETON; TREATMENT PLANNING;

EID: 2542609058     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ghir.2004.03.019     Document Type: Article

References (26)

1. R. Stanhope, P. Hindmarsh, B. Kendall, C.G.D. Brook, High resolution CT scanning of the pituitary gland in growth disorders, Acta Paed. Scand. 75 (1986) 779-786.
2. C. Traggiai, R. Stanhope, Endocrinopathies associated with midline cerebral and cranial malformations, J. Pediatr. 140 (2002) 252-255.
3. V. Nanduri, R. Stanhope, Why is the retention of gonadotrophin secretion common in children with panhypopituitarism due to septo-optic dysplasia?, Eur. J. Endocrinol. 140 (1999) 48-50.
4. C.J. DeVile, R. Sufraz, B. Lask, R. Stanhope, Occult intracranial tumours masquerading as early onset anorexia nervosa, Br. Med. J. 311 (1995) 1359-1360.
5. D. Skuse, A. Albanese, R. Stanhope, J. Gilmour, L. Voss, A new stress related syndrome of growth failure and hyperphagia in children, associated with reversibility of growth hormone insufficiency, Lancet 348 (1996) 353-358.
6. M. Tauber, P. Moulin, C. Pienkowski, B. Jouret, P. Rochiccioli, Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment, J. Clin. Endocrinol. Metab. 82 (1997) 352-356.
7. A. Nicolson, A.A. Toogood, A. Rahim, S.M. Shalet, The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood, Clin. Endocrinol. 44 (1996) 311-316.
8. Z. Laron, O. Butenandt (Eds.), Growth Hormone Replacement Therapy in Adults: Pros and Cons, Freund Publishing House, London - Tel Aviv, 1993.
9. P.E. Clayton, D.A. Price, S.M. Shalet, Growth hormone state after completion of treatment with growth hormone, Arch. Dis. Child 62 (1987) 222-226.
10. E. Cacciari, P. Tassoni, G. Parisi, P. Pirazzoli, S. Succhini, M. Mandini, A. Cocognani, A. Balsamo, Pitfalls in diagnosing impaired growth hormone (GH) secretion: retesting after replacement therapy of 63 patients defined as GH deficient, J. Clin. Endocrinol. Metab. 74 (1992) 1284-1289.
11. S. Wacharasindhu, A.M. Cotterill, C. Carmacho-Hubner, G.M. Besser, M.O. Savage, Normal growth hormone secretion in growth hormone insufficient children retested after completion of linear growth, Clin. Endocrinol. 45 (1996) 553-556.
12. A. Albanese, G. Hamill, J. Jones, D. Skuse, D.R. Matthews, R. Stanhope, Reversibility of physiological growth hormone (GH) secretion in children with psychosocial dwarfism, Clin. Endocrinol. 40 (1994) 687-692.
13. Growth Hormone Research Society, Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society, J. Pediatr. Endocrinol. Metab. 14 (2001) 377-382.
14. Growth Hormone Research Society Workshop in Adult Growth Hormone Deficiency. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on adult growth hormone deficiency, J. Clin. Endocrinol. Metab. 93 (1998) 379-381.
15. J.P. Monson (Ed.), Challenges in Growth Hormone Therapy, Blackwell Science, Oxford, UK, 1999.
16. T. Rosen, B.A. Bengtsson, Premature mortality due to cardiovascular disease in hypopituitarism, Lancet 336 (1990) 285-288.
17. A.S. Bates, W. Van't Hoff, P.J. Jones, R.N. Clayton, The effect of hypopituitarism on life expectancy, J. Clin. Endocrinol. Metab. 81 (1996) 1169-1172.
18. N. Vahl, A. Juul, J.O. Jørgensen, H. Ørskov, N.E. Skakkeback, J.S. Christiansen, Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study, J. Clin. Endocrinol. Metab. 85 (2000) 1874-1881.
19. G. Johannsson, K. Albertsson-Wikland, B.A. Bengtsson, Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for growth hormone treatment in children, J. Clin. Endocrinol. Metab. 84 (1999) 4516-4524.
20. G. Saggese, G.I. Baroncelli, S. Bertelloni, S. Barsanti, The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass, J. Clin. Endocrinol. Metab. 81 (1996) 3077-3083.
21. C.A. Bewbassat, M. Wasserman, Z. Laron, Changes in bone mineral density after discontinuation and early reinstitution of growth hormone (GH) in patients with childhood-onset GH deficiency, Growth Horm. IGF Res. 9 (1999) 290-295.
22. L. Hulthen, B.A. Bengtsson, K.S. Sunnerhagen, L. Hallberg, G. Grimby, G. Joharmsson, GH is needed for the maturation of muscle mass and strength in adolescents, J. Clin. Endocrinol. Metab. 86 (2001) 4765-4770.
23. K. Lagrou, D. Xhrouet-Heinrichs, G. Massa, M. Vandeweghe, J.P. Bourguignon, J. De Schepper, F. de Zegher, C. Ernould, C. Heinrichs, P. Malvaux, M. Craen, Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency, J. Pediatr. Endocrinol. Metab. 14 (Suppl. 5) (2001) 1249-1260.
24. J.P. Monson, The assessment of glucocorticoid replacement therapy, Clin. Endocrinol. 46 (1997) 269-270.
25. C.J. DeVile, R. Stanhope, Hydrocortisone replacement therapy in children and adolescents with hypopituitarism, Clin. Endocrinol. 47 (1997) 37-41.
26. M. Papagianni, R. Stanhope, Should serum IGF-I concentrations be monitored routinely during growth hormone therapy? J. Pediatr. Endocrinol. Metab. 17 (2004) 141-142.